BIMI Holdings Inc (BIMI)
1.36
-0.03
(-2.16%)
USD |
NASDAQ |
Jun 10, 15:59
BIMI Holdings Cash from Investing (Quarterly): -0.6039M for Sept. 30, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.6039M |
| June 30, 2023 | |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.3569M |
| September 30, 2022 | -0.18M |
| June 30, 2022 | -1.678M |
| March 31, 2022 | 1.678M |
| December 31, 2021 | 3.115M |
| September 30, 2021 | -1.517M |
| June 30, 2021 | -0.3268M |
| March 31, 2021 | 0.0391M |
| December 31, 2020 | -11.07M |
| September 30, 2020 | 10.25M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.0952M |
| December 31, 2019 | 0.7378M |
| September 30, 2019 | -0.5711M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.0014M |
| September 30, 2018 | -0.0001M |
| June 30, 2018 | 0.0015M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.0039M |
| September 30, 2017 | 0.0063M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.0024M |
| March 31, 2017 | |
| December 31, 2016 | -0.4057M |
| September 30, 2016 | -0.0018M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | |
| December 31, 2015 | 2.481M |
| September 30, 2015 | -0.7221M |
| June 30, 2015 | 0.0035M |
| March 31, 2015 | -0.1741M |
| December 31, 2014 | -0.0427M |
| September 30, 2014 | -0.1931M |
| June 30, 2014 | -0.1047M |
| March 31, 2014 | -0.0012M |
| December 31, 2013 | -0.1146M |
| September 30, 2013 | -0.0222M |
| June 30, 2013 | -0.7253M |
| March 31, 2013 | -0.0599M |
| December 31, 2012 | -2.748M |
| September 30, 2012 | -0.0282M |
| June 30, 2012 | -0.4678M |
| March 31, 2012 | -0.0061M |
| December 31, 2011 | -0.3844M |
| September 30, 2011 | -0.211M |
| June 30, 2011 | -2.373M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-11.07M
Minimum
Dec 2020
10.25M
Maximum
Sep 2020
-0.0228M
Average
--
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Vanda Pharmaceuticals Inc | -18.22M |
| Sage Therapeutics Inc | 139.44M |
| BioSig Technologies Inc | 0.00 |
| Finch Therapeutics Group Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | 1.068M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.484M |
| Cash from Financing (Quarterly) | 1.033M |
| Free Cash Flow | -3.504M |
| Free Cash Flow Per Share (Quarterly) | -0.3247 |
| Free Cash Flow to Equity (Quarterly) | -2.022M |
| Free Cash Flow to Firm (Quarterly) | -2.052M |
| Free Cash Flow Yield | -55.33% |